Nanoparticle ocular immunotherapy for herpesvirus surface eye infections evaluated in cat infection model

HIGHLIGHTS

• who: Michael Lappin et al. from the Biomedical Sciences, Colorado State University, Fort Collins, Colorado, United States of America have published the article: Nanoparticle ocular immunotherapy for herpesvirus surface eye infections evaluated in cat infection model, in the Journal: PLOS ONE
• what: The authors adapted liposome-dual TLR agonist complexes (LTAC) nanoparticles that the authors previously evaluated for non-specific protection from respiratory tract infections to use as a topical ocular immunotherapeutic . The authors investigated whether immune stimulatory LTAC nanoparticles were effective and safe as a topical ocular immunotherapy to treat surface oriented ocular herpesvirus . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.